Enovis (ENOV) Amortization of Deferred Charges (2010 - 2011)
Enovis' (ENOV) quarterly Amortization of Deferred Charges came in at $187000.0 in Q4 2011, up 10.65% year-over-year from $169000.0 in Q4 2010, and little changed quarter-over-quarter from $187000.0 in Q3 2011.
Powered by 
Analysis
Enovis (ENOV) Amortization of Deferred Charges (2010 - 2011) Analysis & Trends
Enovis (ENOV) has reported Amortization of Deferred Charges for 2 consecutive years, with $187000.0 the latest figure, recorded in Q4 2011.
- On a quarterly basis, Amortization of Deferred Charges rose 10.65% year-over-year to $187000.0 in Q4 2011; TTM through Dec 2011 was $713000.0, a N/A change from a year earlier, with the FY2011 full-year figure at $735000.0, up 8.57% from the prior year.
- Amortization of Deferred Charges was $187000.0 for Q4 2011 at Enovis, roughly flat from $187000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $187000.0 in Q3 2011 and troughed at $169000.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.41 Bn | 175.81 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.31 Bn | 1.96 Bn |
| 3 | Medtronic | 117.19 Bn | 108.37 Bn | 6.34 Bn |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.49 Bn | 63.95 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.93 Bn | 45.68 Bn | 1.35 Bn |
| 7 | Alcon | 33.08 Bn | 31.62 Bn | 1.68 Bn |
| 8 | Dexcom | 32.21 Bn | 30.26 Bn | 830.00 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 187,000.00 |
| Sep 30, 2011 | 187,000.00 |
| Dec 31, 2010 | 169,000.00 |
| Oct 1, 2010 | 170,000.00 |